Skip to main content
News

DMT Shows Promise in Treating Depression, Study Finds

1 min read

A clinical trial suggests that DMT, paired with therapy, may help alleviate symptoms of depression, offering hope for those with treatment-resistant cases.

Read the story at The Guardian (opens in a new tab)

Originally reported by The Guardian. Senior Wellness summarises the reporting; we do not publish the original article.

According to The Guardian, a recent clinical trial has highlighted the potential of the psychedelic drug dimethyltryptamine (DMT) combined with psychotherapy to treat major depressive disorder. The study involved 34 participants with treatment-resistant depression, who received either a single dose of DMT or a placebo.

The trial found that those who received DMT experienced a significant reduction in depressive symptoms, with improvements lasting from three to six months. This suggests that DMT-assisted therapy could offer a new avenue for those who do not respond to traditional antidepressants.

DMT is a powerful psychedelic often used in shamanistic rituals in South America. The trial was conducted by researchers at Imperial College London and was funded by Cybin UK. It is part of a larger trend exploring psychedelics as potential treatments for mental health issues.

While these findings are promising, the study is still in its early stages. As such, older adults considering new treatment options should consult with their healthcare providers for guidance tailored to their specific needs.